Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system.
about
Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assayFrom principle to practice: bridging the gap in patient profilingProthrombin Complex Concentrates for Bleeding in the Perioperative Setting.Moderate plasma dilution using artificial plasma expanders shifts the haemostatic balance to hypercoagulation.Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome.Thrombin induces endothelial arginase through AP-1 activation.Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.Structure and function of factor XIProcoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice.Clinical review: Prothrombin complex concentrates--evaluation of safety and thrombogenicity.Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Influence of Acute Normobaric Hypoxia on Hemostasis in Volunteers with and without Acute Mountain Sickness.Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.Basic aspects of bypassing agents.Thrombin generation, fibrin clot formation and hemostasisDiagnostic approach to inherited bleeding disorders.Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience.Reduced thrombin generation increases host susceptibility to group A streptococcal infectionSystemic blood coagulation activation in acute coronary syndromes.New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors.Elevated prothrombin promotes venous, but not arterial, thrombosis in mice.Thrombelastography and tromboelastometry in assessing coagulopathy in trauma.Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome.Health effects of particulate air pollution: A review of epidemiological evidence.Transfusion medicine in trauma patients: an update.Modeling thrombin generation: plasma composition based approach.Using aptamers as capture reagents in bead-based assay systems for diagnostics and hit identification.Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease.Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer.Concentration-Dependent Dual Role of Thrombin in Protection of Cultured Rat Cortical Neurons.Progressive improvement in wound healing with increased therapy in haemophilia B mice.Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease.Current issues facing coagulationists--meeting report.Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia.Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography.Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist.A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia B.Recombinant factor VIIa: a general hemostatic agent? Yes.
P2860
Q24812269-46F5511F-1E32-432B-BE05-E12AD96FB53DQ27318447-08D9D3D5-064A-410A-8304-C9994ECA5B34Q33430766-6A4B5608-C18D-4653-BC06-12232C7DC152Q33678363-F1E04C1B-6872-4B19-B74D-C42ADF6DF53CQ33750461-4A49E868-56E2-43DB-9B08-27194E8AED3CQ33783523-E6E93C3C-D9ED-4E75-B1D9-3DD38EB31330Q33934481-7E1D429B-7895-4654-BFA0-D1BE95EB185CQ34095400-F47B02D7-50C8-4A34-89BF-922CDE51B1AEQ35346495-6E40D31C-05CB-4380-9499-479B8745648BQ35567088-F0008338-43F9-4A86-8DBE-C48C431F6223Q35690807-9D83FC55-04EF-4E92-8CAA-25E5D869B228Q36103223-7561B333-64E1-4C46-918E-0A4F480026B9Q36283835-31405FD5-AB0C-4009-B007-D801D45B15ABQ36462093-4A4314D3-A1B2-4250-B5C9-E043697DAFB3Q36661832-CC6BA5E0-B035-48B0-BE6F-9E481D2BFA69Q36691794-58B8E171-052B-4DD0-BE1E-2056A88A9D17Q36715734-D040395F-C6C5-460F-968D-8F47DC45200DQ36819965-6E0BA390-9F1E-451D-BDEE-1306C816FA95Q37086949-B7CEAD8B-4C83-401A-A866-1E57F7D20D0CQ37116951-1F9BFA58-03FE-45BA-A8CE-FBC4BF9315E0Q37169669-5BAA7EF4-51D8-4CF6-90B4-98626D479420Q37189156-08DD37B9-C750-439F-9199-14BE4992431DQ37379818-7296280C-B1AD-43EF-81A2-ECFC09DC20A7Q37900368-C4F48CF9-2591-4F64-98DD-EBE2095AA502Q37921792-9A8C363F-5298-4423-ACD4-DEE421DD287CQ37937042-7575152E-D8CB-4FA5-BDD9-FC7E60D4A59CQ38161459-2ED9B08D-736D-41A5-850E-DFED32819299Q38310154-5A022628-9EE2-4D7E-BCA8-855FA0787169Q41828146-173665E1-9B35-43C6-AA6B-10ED937962BDQ42922540-798A8E70-9171-4FDB-904D-BD9828FFA67BQ43177281-49035381-7E37-4FA6-8A21-23E29DE0A407Q44088511-B1C46D8B-77A7-4786-B3C6-640D60AC9D5DQ44916643-0FFC701D-C3F5-4E0E-A8B2-FFD97E30FB1EQ45856057-A4B0768F-EEF1-4E8C-A932-2168B7E2482BQ45859169-FA1AFE41-6CB1-4087-BB1F-94C2ABE3DFB4Q45863543-9768C119-6848-43CD-9D7C-088B312DD5CCQ45865116-6028E320-7EAA-4783-93D0-4DD69A8777E9Q45868696-9DE36D1A-3E79-46AA-9E9B-23AFAD379DC4Q45872780-30997F2F-9FF5-42AE-AE6F-C722593C96BDQ45878443-B1DF58CE-F73F-4FF9-BF58-89A008983B8C
P2860
Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Impact of procoagulant concent ...... generation in a model system.
@en
Impact of procoagulant concent ...... generation in a model system.
@nl
type
label
Impact of procoagulant concent ...... generation in a model system.
@en
Impact of procoagulant concent ...... generation in a model system.
@nl
prefLabel
Impact of procoagulant concent ...... generation in a model system.
@en
Impact of procoagulant concent ...... generation in a model system.
@nl
P2093
P2860
P50
P1476
Impact of procoagulant concent ...... generation in a model system.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7933.2003.00617.X
P577
2004-03-01T00:00:00Z